我要投票 南京高科在房地产行业中的票数:8
· 外 推 电 报 ·
2024-11-22 21:21:15 星期五

【南京高科是哪个国家的品牌?】

南京高科是什么牌子?「南京高科」是 南京高科股份有限公司 旗下著名品牌。该品牌发源于江苏省南京市,由创始人徐董在1992年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

南京高科股份有限公司(股票简称:南京高科;股票代码:600064)是1992年7月4日经南京市经济体制改革委员会批准设立的定向募集股份有限公司,目前注册资本7.72亿元。1997年5月6日在上海证券交易所挂牌上市。公司主营:高新技术产业投资、开发;市政基础设施建设、投资及管理;土地成片开发;建筑安装工程;商品房开发、销售;物业管理;自有房屋租赁;工程设计;咨询服务;污水处理、环保项目建设、投资及管理。公司控股股东为南京新港开发总公司,实际控制人为南京市人民政府国有资产监督管理委员会。

上市20年来,公司抓住资本市场大发展的机遇,依托上市公司的品牌优势、资金优势,在立足开发区建设和经营的同时,以实现持续成长为目标,积极培育公司新的利润增长点。公司培育或投资了包括高科置业、臣功制药、南京银行、栖霞建设、中信证券、南京证券、LG新港、广州农商行等一批资产质量优良、盈利能力突出的优质企业,搭建了公司未来可持续发展的产业架构,保障了各项业务稳步增长的良好态势。公司上市后多次进行利润分配,在向股东送红股和转增股本的同时,累计分配现金红利逾19亿元,超过了公司两次募集资金总额,充分体现了公司“为股东创造价值”的经营理念。

公司董事会下设战略、审计、提名、薪酬与考核四个专业委员会,总部形成了包括办公室、人力资源部、计划财务部、投资管理部、运营管理部和审计部“一室五部”的组织架构,建立了组织架构和公司治理体系。公司旗下现有高科置业、高科建设、臣功制药、高科新创、高科科贷等7家控股子公司、13家参股子公司,产业横跨房地产、市政、医药、股权投资等多个领域,搭建了投资控股型集团公司模式。

展望未来,公司将继续秉承“整合资源、创造价值”的经营理念,在稳步发展房地产市政等传统主营业务同时,加快“大健康、大创投”的战略转型步伐,着力将公司打造成为“健康+创投”特色鲜明的上市公司,为股东创造更大的价值!


英文翻译:Nanjing High Tech Co., Ltd. (stock abbreviation: Nanjing high tech; Stock Code: 600064) is a directional raising Co., Ltd. established on July 4, 1992 with the approval of Nanjing Economic System Reform Commission. At present, its registered capital is 772 million yuan. It was listed on the Shanghai Stock Exchange on May 6, 1997. The company's main businesses include: investment and development of high-tech industry; municipal infrastructure construction, investment and management; land development; construction and installation engineering; commercial housing development and sales; property management; self owned housing leasing; engineering design; consulting services; sewage treatment, environmental protection project construction, investment and management. The controlling shareholder of the company is Nanjing Xingang Development Corporation, and the actual controller is the state owned assets supervision and Administration Commission of Nanjing Municipal People's government. In the past 20 years of listing, the company has seized the opportunity of great development of the capital market, relied on the brand and capital advantages of the listed company, and based on the construction and operation of the Development Zone, with the goal of achieving sustainable growth, actively cultivated the company's new profit growth point. The company has cultivated or invested a number of high-quality enterprises with excellent asset quality and outstanding profitability, including hi tech real estate, Chenggong pharmaceutical, Bank of Nanjing, Qixia construction, CITIC Securities, Nanjing Securities, LG new port, Guangzhou agricultural commercial bank, etc., built the company's industrial structure for sustainable development in the future, and guaranteed a good momentum of steady growth of various businesses. After the listing of the company, profit distribution has been carried out for many times. At the same time of sending bonus shares and increasing share capital to shareholders, the accumulated cash dividend has been distributed more than 1.9 billion yuan, which exceeds the total amount of funds raised by the company twice, fully reflecting the company's business philosophy of "creating value for shareholders". The company's board of Directors consists of four professional committees: strategy, audit, nomination, remuneration and assessment. The headquarters has formed an organizational structure of "one office, five departments" including the office, human resources department, planning and finance department, investment management department, operation management department and audit department, and established an organizational structure and corporate governance system. The company has 7 holding subsidiaries and 13 participating subsidiaries, including hi-tech real estate, hi-tech construction, Chenggong pharmaceutical, hi-tech innovation and hi-tech loan. The industry spans real estate, municipal administration, medicine, equity investment and other fields, and has built an investment holding group company model. Looking forward to the future, the company will continue to uphold the business philosophy of "integrating resources and creating value", while steadily developing the traditional main business such as real estate and municipal administration, accelerate the strategic transformation of "big health and big venture capital", and strive to build the company into a listed company with distinctive characteristics of "health + venture capital" to create greater value for shareholders!

本文链接: https://www.waitui.com/brand/c0e9ba0f3.html 联系电话:025-85800700

千城特选小程序码

7×24h 快讯

梅花生物:拟105亿日元收购协和发酵旗下的食品氨基酸等业务及资产

36氪获悉,梅花生物发布公告,全资子公司新加坡公司拟以105亿日元(折合人民币约5亿元左右)收购Kirin Holdings Company, Limited(简称“麒麟控股”,东京证券交易所上市公司,股票代码2503.T)的全资子公司Kyowa Hakko Bio Co., Ltd.(协和发酵株式会社,简称“协和发酵”)旗下的食品氨基酸、医药氨基酸、母乳低聚糖业务及资产。

2小时前

三鑫医疗:获得医疗器械注册证

36氪获悉,三鑫医疗发布公告,公司及控股子公司宁波菲拉尔医疗用品有限公司于近日分别获得了国家药监局颁发的血液透析滤过器、一次性使用右心吸引头《医疗器械注册证》。

2小时前

上海电影:拟收购上影元19%股权

36氪获悉,上海电影发布公告,公司拟以现金形式收购控股股东上影集团、上美影分别持有的公司控股子公司上影元(上海)文化科技发展有限公司(简称上影元)14%、5%股权,对应转让价格预计分别为不超过4902.8万元、1751万元。本次交易完成后,上影元股权结构为公司持股70%,上美影持股30%。

2小时前

英国监管机构拟调查苹果与谷歌的移动生态系统活动

英国竞争与市场管理局(CMA)11月22日发布声明称,正考虑根据明年生效的数字市场竞争新规优先调查苹果和谷歌的移动生态系统活动。CMA独立调查小组的研究发现,苹果和谷歌在移动生态系统形成了实际上的“双头垄断”,包括移动设备上的操作系统、应用商店和网络浏览器。该小组认为,苹果的政策阻碍了移动浏览器的创新。CMA表示,将在当地时间12月13日前邀请公众就上述临时调查结果发表评论,预计将在明年3月做出最终决定。(界面)

2小时前

​中晟高科:拟4.57亿元出售中晟新材100%股权

36氪获悉,中晟高科发布公告,公司通过在产权交易中心公开挂牌转让的方式,出售持有的中晟新材100%股权。在首次挂牌信息发布期限内征集到意向受让方泷祥投资,本次标的资产交易对方确定为泷祥投资,交易对价确定为4.57亿元。

2小时前

本页详细列出关于运盛实业的品牌信息,含品牌所属公司介绍,运盛实业所处行业的品牌地位及优势。
咨询